Steven M Shantz

Title: Inventor Spotlight: Steven M. Shantz

Introduction

Steven M. Shantz, an innovative inventor based in Goshen, IN, has made significant contributions to the field of enzymatic testing and stabilization. With a career marked by creativity and scientific rigor, he holds two patents that showcase his dedication to advancing methodologies in biochemistry.

Latest Patents

Shantz's latest patents illustrate his expertise and innovative approach. The first patent, titled "Method of preserving arylacylamidase in aqueous solution," focuses on stabilizing the enzyme arylacylamidase by inhibiting conformational changes using compounds such as o-cresol and benzoic acid. This advancement significantly enhances the stability of arylacylamidase in various formats, making it invaluable for biotechnological applications.

The second patent, "Test composition and method for the determination of anilides," describes a novel method for estimating anilides through enzymatic hydrolysis and colorimetric quantitation. This streamlined process allows for simultaneous reactions, facilitating a one-step addition of reagents, which simplifies testing in automated analyzers. A unique combination of arylacylamidase and controlled organic compounds creates a system that not only stabilizes the enzyme but also accelerates color development for efficient testing.

Career Highlights

Steven M. Shantz works with GDS Technology, Inc., where he continues to explore innovative solutions in the field of enzymology. His deep understanding of biochemistry and his contributions to enzyme stabilization and testing methodologies have positioned him as a significant figure in his field.

Collaborations

Throughout his career, Shantz has collaborated with leading experts in his area, including Aurora F. deCastro and Surendra K. Gupta. These partnerships have enriched his research and development processes, fostering an environment of collective innovation.

Conclusion

Steven M. Shantz exemplifies the spirit of innovation and scientific advancement. His patents demonstrate a commitment to improving biological testing methods, making significant strides in the field of enzymatic chemistry. As he continues to work with GDS Technology, Inc., the impact of his inventions is likely to be felt across various scientific and industrial applications.